ZA992255B - Antitumor synergetic composition. - Google Patents

Antitumor synergetic composition.

Info

Publication number
ZA992255B
ZA992255B ZA9902255A ZA992255A ZA992255B ZA 992255 B ZA992255 B ZA 992255B ZA 9902255 A ZA9902255 A ZA 9902255A ZA 992255 A ZA992255 A ZA 992255A ZA 992255 B ZA992255 B ZA 992255B
Authority
ZA
South Africa
Prior art keywords
antitumor
synergetic composition
synergetic
composition
antitumor synergetic
Prior art date
Application number
ZA9902255A
Inventor
Cristina Geroni
Marina Ripamonti
Michele Caruso
Antonino Suarato
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Publication of ZA992255B publication Critical patent/ZA992255B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
ZA9902255A 1998-03-24 1999-03-23 Antitumor synergetic composition. ZA992255B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9806324.1A GB9806324D0 (en) 1998-03-24 1998-03-24 Antitumour synergetic composition

Publications (1)

Publication Number Publication Date
ZA992255B true ZA992255B (en) 1999-10-05

Family

ID=10829188

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9902255A ZA992255B (en) 1998-03-24 1999-03-23 Antitumor synergetic composition.

Country Status (29)

Country Link
US (1) US6403563B1 (en)
EP (1) EP1067941B1 (en)
JP (1) JP2002507571A (en)
KR (1) KR20010034619A (en)
CN (2) CN1150002C (en)
AR (1) AR018166A1 (en)
AT (1) ATE271388T1 (en)
AU (1) AU758191B2 (en)
BR (1) BR9908391A (en)
CA (1) CA2324610A1 (en)
CZ (1) CZ295368B6 (en)
DE (1) DE69918819T2 (en)
DK (1) DK1067941T3 (en)
EA (1) EA003134B1 (en)
ES (1) ES2226366T3 (en)
GB (1) GB9806324D0 (en)
HU (1) HUP0101615A3 (en)
ID (1) ID26091A (en)
IL (1) IL138035A0 (en)
MY (1) MY133016A (en)
NO (1) NO20004703D0 (en)
NZ (1) NZ507570A (en)
PL (1) PL343098A1 (en)
PT (1) PT1067941E (en)
SI (1) SI1067941T1 (en)
TW (1) TW576740B (en)
UA (1) UA63000C2 (en)
WO (1) WO1999048503A1 (en)
ZA (1) ZA992255B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6820065B1 (en) * 1998-03-18 2004-11-16 Ascom Hasler Mailing Systems Inc. System and method for management of postage meter licenses
GB9904387D0 (en) * 1999-02-25 1999-04-21 Pharmacia & Upjohn Spa Antitumour synergistic composition
GB9909925D0 (en) 1999-04-29 1999-06-30 Pharmacia & Upjohn Spa Combined preparations comprising anthracycline derivatives
GB9916882D0 (en) * 1999-07-19 1999-09-22 Pharmacia & Upjohn Spa Antitumor synergistic composition
GB9926843D0 (en) * 1999-11-12 2000-01-12 Pharmacia & Upjohn Spa Lipid complex of alkycyclines
US6627614B1 (en) * 2002-06-05 2003-09-30 Super Gen, Inc. Sequential therapy comprising a 20(S)-camptothecin and an anthracycline
EP1985286A1 (en) * 2007-04-24 2008-10-29 Biocompatibles UK Limited Microspheres for treatment of brain tumours
US8349764B2 (en) 2007-10-31 2013-01-08 Molycorp Minerals, Llc Composition for treating a fluid
US20090107925A1 (en) * 2007-10-31 2009-04-30 Chevron U.S.A. Inc. Apparatus and process for treating an aqueous solution containing biological contaminants
US20110207760A1 (en) * 2010-02-23 2011-08-25 Valery Alakhov Sn-38 compositions
DK3012329T3 (en) 2010-06-18 2017-11-20 Myriad Genetics Inc METHODS AND MATERIALS FOR ASSESSING LOSS OF HETEROZYGOSITY
CA2807823C (en) 2010-08-24 2023-02-07 The Brigham And Women's Hospital, Inc. Methods for predicting anti-cancer response
US9233863B2 (en) 2011-04-13 2016-01-12 Molycorp Minerals, Llc Rare earth removal of hydrated and hydroxyl species
WO2012174378A2 (en) 2011-06-17 2012-12-20 Myriad Genetics, Inc. Methods and materials for assessing allelic imbalance
AU2012358244A1 (en) 2011-12-21 2014-06-12 Myriad Genetics, Inc. Methods and materials for assessing loss of heterozygosity
DK2817630T3 (en) 2012-02-23 2018-10-08 Childrens Medical Center Methods for predicting an anti-cancer response
CA3190075A1 (en) 2012-06-07 2013-12-12 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
US10308986B2 (en) 2013-03-14 2019-06-04 Children's Medical Center Corporation Cancer diagnosis, treatment selection and treatment
WO2014165785A2 (en) 2013-04-05 2014-10-09 Myriad Genetics, Inc. Methods and materials for assessing homologous recombination deficiency
WO2015086473A1 (en) 2013-12-09 2015-06-18 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
MX370462B (en) 2014-03-07 2019-12-13 Secure Natural Resources Llc Cerium (iv) oxide with exceptional arsenic removal properties.
DK3180447T3 (en) 2014-08-15 2020-06-15 Myriad Genetics Inc METHODS AND MATERIALS FOR ANALYSIS OF HOMOLOGICAL RECOMBINATION DEFICIENCY
EP4141127A1 (en) 2021-08-30 2023-03-01 Zentrum Familiärer Brust- und Eierstockkrebs Universitätsklinik Köln Method for assessing homologous recombination deficiency in ovarian cancer cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9114549D0 (en) * 1991-07-05 1991-08-21 Erba Carlo Spa Mono and bis alkylamino-anthracyclines
GB9325417D0 (en) * 1993-12-13 1994-02-16 Erba Carlo Spa 3'- aziridino-anthracycline derivatives

Also Published As

Publication number Publication date
WO1999048503A1 (en) 1999-09-30
AR018166A1 (en) 2001-10-31
HUP0101615A3 (en) 2002-12-28
EP1067941B1 (en) 2004-07-21
EA003134B1 (en) 2003-02-27
CN1150002C (en) 2004-05-19
PT1067941E (en) 2004-12-31
KR20010034619A (en) 2001-04-25
CN1528334A (en) 2004-09-15
CZ295368B6 (en) 2005-07-13
NO20004703L (en) 2000-09-20
SI1067941T1 (en) 2005-02-28
CN1294516A (en) 2001-05-09
CA2324610A1 (en) 1999-09-30
JP2002507571A (en) 2002-03-12
MY133016A (en) 2007-10-31
DE69918819T2 (en) 2005-08-18
EP1067941A1 (en) 2001-01-17
BR9908391A (en) 2000-10-31
TW576740B (en) 2004-02-21
UA63000C2 (en) 2004-01-15
NZ507570A (en) 2003-01-31
AU758191B2 (en) 2003-03-20
CZ20003493A3 (en) 2001-02-14
AU3331499A (en) 1999-10-18
ES2226366T3 (en) 2005-03-16
PL343098A1 (en) 2001-07-30
HUP0101615A2 (en) 2001-10-28
DK1067941T3 (en) 2004-11-29
NO20004703D0 (en) 2000-09-20
IL138035A0 (en) 2001-10-31
GB9806324D0 (en) 1998-05-20
ATE271388T1 (en) 2004-08-15
ID26091A (en) 2000-11-23
US6403563B1 (en) 2002-06-11
DE69918819D1 (en) 2004-08-26
EA200000978A1 (en) 2001-02-26

Similar Documents

Publication Publication Date Title
ZA992255B (en) Antitumor synergetic composition.
ZA996185B (en) Sulfanylsilanes.
ZA200005136B (en) Dihydropyrimides.
HK1053050A1 (en) Bra.
ZA9811959B (en) Ibuprofen composition.
HK1038690A1 (en) Powdery pernasal compositions.
ZA991014B (en) Pesticidal compositions.
ZA99254B (en) Benzosulfone derivatives.
HK1038884A1 (en) Medicinal compositions.
PL348326A1 (en) Combination chemotherapy
HK1042999A1 (en) Wdm-channel equalizer.
ZA200005510B (en) Pharmaceutical composition.
HK1041482A1 (en) Naphtho-and dihydrobenzo-thiophene derivatives as cytotoxic antitumor agents.
ZA992443B (en) Hydroxy-methyl-hexanones.
ZA991550B (en) Cyclohexanediole derivatives.
ZA995325B (en) Methylcyclotetradec-5-en-1-ones.
ZA993123B (en) Trisresorcinyltriazines.
HK1036280A1 (en) Antivirals.
ZA993197B (en) Pesticidal composition.
ZA995239B (en) Pesticidal compositions.
HK1044117A1 (en) Pharmaceutical composition.
ZA200006118B (en) Novel composition.
ZA99890B (en) Pharmaceutical compositions.
ZA200000192B (en) Novel composition.
HK1042249A1 (en) Anti-tumor synergetic composition